- Home
- IMTE vs KZIA Comparison
IMTE vs KZIA Comparison
Compare IMTE & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- KZIA
- Stock Information
- Founded
- IMTE 2008
- KZIA 1994
- Country
- IMTE Malaysia
- KZIA Australia
- Employees
- IMTE N/A
- KZIA N/A
- Industry
- IMTE Consumer Electronics/Appliances
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- KZIA Health Care
- Exchange
- IMTE Nasdaq
- KZIA Nasdaq
- Market Cap
- IMTE 4.2M
- KZIA 6.0M
- IPO Year
- IMTE N/A
- KZIA 1999
- Fundamental
- Price
- IMTE $1.03
- KZIA $0.90
- Analyst Decision
- IMTE
- KZIA Strong Buy
- Analyst Count
- IMTE 0
- KZIA 2
- Target Price
- IMTE N/A
- KZIA $11.50
- AVG Volume (30 Days)
- IMTE 5.0K
- KZIA 412.2K
- Earning Date
- IMTE 03-25-2025
- KZIA 03-26-2025
- Dividend Yield
- IMTE N/A
- KZIA N/A
- EPS Growth
- IMTE N/A
- KZIA N/A
- EPS
- IMTE N/A
- KZIA N/A
- Revenue
- IMTE $123,337.00
- KZIA $1,655,324.00
- Revenue This Year
- IMTE N/A
- KZIA N/A
- Revenue Next Year
- IMTE N/A
- KZIA N/A
- P/E Ratio
- IMTE N/A
- KZIA N/A
- Revenue Growth
- IMTE 4.75
- KZIA 248000.00
- 52 Week Low
- IMTE $1.04
- KZIA $0.76
- 52 Week High
- IMTE $3.84
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- IMTE 33.41
- KZIA 41.81
- Support Level
- IMTE $1.11
- KZIA $0.78
- Resistance Level
- IMTE $1.20
- KZIA $1.44
- Average True Range (ATR)
- IMTE 0.07
- KZIA 0.13
- MACD
- IMTE -0.01
- KZIA 0.06
- Stochastic Oscillator
- IMTE 6.90
- KZIA 20.35
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.